Certara has announced that the US Food and Drug Administration (FDA) has renewed, and in many cases increased, its number of Certara software licenses for reviewing new drug and biologics applications
Certara has announced that it has Pirana, a product for connecting and organising pharmacometric modelling results as well as providing interfaces to a range of software tools used in pharmacometrics modelling
Certara, a provider of model-informed drug development, has announced the launch of D360 v10.5, the first in a series of releases focused on delivering biologic-relevant tools together with D360’s world-class data access capabilities
Certara has reported that 95 per cent of novel new drug approvals by the US Food and Drug Administration (FDA) in the first half of 2018 was supported by Certara software or services
Certara, a provider of in model-informed drug development, regulatory science, market access and real-world evidence services, has announced the launch of Analytica Laser’s Market Access Radar, a three times weekly market access intelligence briefing.
This market access data is also available via an easily searchable web portal.
Certara, a provider of model-informed drug development and regulatory science, has announced that it has acquired Analytica Laser
Certara, the global leader in model-informed drug development and regulatory science, today announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium
The failure of a candidate drug can cost millions – so many chemists are turning to software that provides modelling capabilities and multi-parameter optimisation
Robert Roe looks back over the year at technology and processes driving trends in the laboratory
Certara, a provider of model-informed drug development and regulatory science, today announced that it has published two papers demonstrating proof of concept for its Virtual Twin technology
Robert Roe reports on developments in AI that are helping to shape the future of high performance computing technology at the International Supercomputing Conference
James Reinders is a parallel programming and HPC expert with more than 27 years’ experience working for Intel until his retirement in 2017. In this article Reinders gives his take on the use of roofline estimation as a tool for code optimisation in HPC
Sophia Ktori concludes her two-part series exploring the use of laboratory informatics software in regulated industries.
As storage technology adapts to changing HPC workloads, Robert Roe looks at the technologies that could help to enhance performance and accessibility of
storage in HPC